Worked with C-suite and an accounting firm to conduct an economic analysis, structure, and implement intercompany payments and agreements in preparation for an IPO of an innovative biotech incubator. The analysis included valuation of a unique biotech development and production facility, R&D, engineering and management services.
2024 International Arbitration review: Updates and trends
Dear Clients and Friends, Our activities in 2024 reflected ongoing trends from 2023 and emerging forces affecting the landscape for investors and companies...